bioRxivPharmacology & ToxicologyPreprint
Bisdemethoxycurcumin mitigates Alzheimer disease pathology through autophagy-mediated reduction of senescence and amyloid beta
Parul Khajuria, Dilpreet KouriD, Kuhu Sharma, Lakhvinder Singh, Razia Banoo, Diksha Manhas, P. Ramajayan, Utpal NandiiD, Sandip Bibishan BharateiD, Zabeer AhmediD, Ajay KumariD
- Citations
- 1
Abstract
AD pathology is accompanied by increased senescence and reduced levels of autophagy in the brain. We investigated whether pharmacologically inducing autophagy could alter the senescent phenotype and help ameliorate AD pathology. We discovered that Bisdemethoxycurcumin (BDMC), a natural compound found in Curcuma longa, stimulates autophagy in primary astrocytes. We found that autophagy and senescence exhibit an inverse relationship in aging astrocytes, with increased expression of senescent proteins and downregulation of autophagic proteins. However, treatment of aged astrocytes with BDMC reversed the senescent phenotype by ameliorating the impaired autophagy. Interestingly, the senescent phenotype persisted when autophagy was downregulated by knockdown of AMPK. Additionally, BDMC-induced autophagy aided in the removal of amyloid beta that was administered externally to the astrocytes. Further, to validate these results in a mouse model of AD, we confirmed that BDMC can significantly penetrate the blood-brain barrier (BBB) in mice. Therefore, we administered 50 and 100 mg/kg b.w. of BDMC to transgenic 3xTg-AD mice for two months. In their hippocampus, the Control 3xTg-AD animals showed more senescent cells and lower autophagy levels. In contrast, autophagic proteins were significantly upregulated while senescence indicators, such as senescence-associated secretory phenotype (SASP) proteins, were sharply downregulated in the brain of treated animals. Additionally, we discovered that the treated mices hippocampus had a significantly lower amyloid beta load. These molecular changes in the brain were ultimately reflected in the improved working memory and neuromuscular coordination behavior of mice treated with BDMC. This study warrants further evaluation of BDMC for the management of AD. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/654834v1_ufig1.gif" ALT="Figure 1"> View larger version (53K): org.highwire.dtl.DTLVardef@1176bbforg.highwire.dtl.DTLVardef@a2e2cdorg.highwire.dtl.DTLVardef@1d824f5org.highwire.dtl.DTLVardef@1628a30_HPS_FORMAT_FIGEXP M_FIG This illustration was created by using biorender.com C_FIG
- organism: mouse
- assay: proteomics
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Telomere-induced senescence increases aberrant intraneuronal amyloid-β accumulation by impairing autophagy in a mouse model of Alzheimer's disease
Núria Suelves, Shirine Saleki, … Pascal Kienlen‐Campard·Acta Neuropathologica CommunicationsPeer-reviewed·May 17, 2023
- Astrocyte senescence in an Alzheimer’s disease mouse model is mediated by TGF-β1 and results in neurotoxicity
Shoshik Amram, Tal Iram, … Dan Frenkel·bioRxiv·Jul 12, 2019
- Δ133p53α Protects Human Astrocytes from Amyloid-Beta Induced Senescence and Neurotoxicity
Kyra Ungerleider, Jessica A. Beck, … Curtis C. Harris·bioRxiv·May 17, 2021
- Attenuating amyloid-beta pathology in mice with in situ programmed astrocytes
Lun Zhang, Shuai Lü, … Rui‐tian Liu·bioRxiv·Oct 30, 2023
- The autophagy activator Spermidine ameliorates Alzheimer's disease pathology and neuroinflammation in mice
Kiara Freitag, Nele Sterczyk, … Marina Jendrach·bioRxiv·Dec 27, 2020
- Amyloid beta oligomers modulate neuronal autophagy through the primary cilium
Olatz Pampliega, Federico Nicolás Soria, … Erwan Bézard·bioRxiv·Jun 2, 2021